Procrit (epoetin alfa), Retacrit (epoetin alfa-epbx). Mircera Epogen/Procrit/Retacrit: 5 years of age and older. Aranesp: 18 years
Aranesp, Epogen, Mircera, Procrit and Retacrit are erythropoiesis Stimulating Agents (ESA) which promote the Separated Rx vs MB policies.
Retacrit is a biosimilar to Epogen/Procrit, two drugs used to treat anemia and reduce blood transfusions. It has the same indications, warnings, and labeling as Epogen/Procrit, but is not interchangeable with them.
RETACRIT does not have a designation of interchangeability with Epogen/Procrit. RETACRIT (epoetin alfa-epbx) Product Monograph BUILDING ONTO THE CLINICAL EXPERIENCE OF EPOETIN ALFA RETACRIT is the first and only FDA-approved biosimilar to Epogen /Procrit (epoetin alfa) with single- and multiple-dose vials1-3 Next Summary Totality of
Compare Mircera vs Procrit head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Other epoetin alfa brands include: Epogen, Retacrit:
RETACRIT is the first and only FDA-approved biosimilar of Epogen/Procrit available in both single- and multiple-dose vials1,2. RETACRIT is available in
Retacrit is biosimilar to the drugs Epogen and Procrit.
Retacrit is a biological product that is similar to Epogen/Procrit, which are used to treat anemia caused by various conditions. Retacrit has the same side effects, warnings and indications as Epogen/Procrit, and is not interchangeable with them.
10,000 units/mL (Epogen, Procrit, Retacrit); 20,000 units/mL (Epogen, Procrit, Retacrit); 40,000 units/mL (Retacrit). Biosimilar to Epogen and Procrit. Retacrit
then vs than
accept vs expect
alright vs all right
its vs it's
there vs their
waist vs waste
your vs you're, you are